scispace - formally typeset
R

Robert A. Rosenheck

Researcher at Yale University

Publications -  993
Citations -  58354

Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

One-year use and cost of inpatient and outpatient services among Female and male patients with an eating disorder: Evidence from a national database of health insurance claims

Ruth H. Striegel-Moore, +6 more
- 01 May 2000 - 
TL;DR: Female patients were significantly more likely to have been treated for an eating disorder than male patients, and females received more days of treatment than males, and age-adjusted costs for the treatment of anorexia nervosa and bulimia nervosa were comparable to the cost of treatment for schizophrenia.
Journal ArticleDOI

An empirical conceptualization of the recovery orientation

Sandra G. Resnick, +3 more
- 01 Jun 2005 - 
TL;DR: There is a bidirectional relationship between recovery attitudes and the positive clinical outcomes that are the goals of EBPs and the evidence-based practice (EBP) movement may help to identify interventions that promote the recovery orientation and help to advance recovery attitudes.
Journal ArticleDOI

Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic

T. Scott Stroup, +10 more
TL;DR: Among this group of patients with chronic schizophrenia who had just discontinued treatment with an atypical antipsychotic, risperidone and olanzapine were more effective than quetiapine and ziprasidone as reflected by longer time until discontinuation for any reason.
Journal ArticleDOI

Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia

Somaia Mohamed, +5 more
- 01 Mar 2009 - 
TL;DR: Greater patient understanding of their illness and more positive attitudes toward medication may improve outcomes and educational interventions that affect these attitudes may be an important part of psychosocial rehabilitation and/or recovery-oriented services.
Journal ArticleDOI

Extrapyramidal side-effects of antipsychotics in a randomised trial

Del D. Miller, +11 more
- 01 Oct 2008 - 
TL;DR: The incidence of treatment-emergent EPS and change in EPS ratings indicated that there are no significant differences between second-generation antipsychotics and perphenazine or between second theses antipsychotic drugs in people with schizophrenia.